Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques.

Brouwer A, De Laere B, van Dam PJ, Peeters D, Van Haver J, Sluydts E, El Moussaoui A, Mendelaar P, Kraan J, Peeters M, Van Laere S, Dirix L.

PLoS One. 2019 Sep 4;14(9):e0220906. doi: 10.1371/journal.pone.0220906. eCollection 2019.

2.

Using Lempel-Ziv complexity as effective classification tool of the sleep-related breathing disorders.

Pregowska A, Proniewska K, van Dam P, Szczepanski J.

Comput Methods Programs Biomed. 2019 Aug 24;182:105052. doi: 10.1016/j.cmpb.2019.105052. [Epub ahead of print]

PMID:
31476448
3.

The use of buparlisib as a radiosentisiser: What about toxicity?

van Dam PA.

Eur J Cancer. 2019 Aug 16. pii: S0959-8049(19)30418-6. doi: 10.1016/j.ejca.2019.06.026. [Epub ahead of print] No abstract available.

PMID:
31427119
4.

Learning in Practice: Collaboration Is the Way to Improve Health System Outcomes.

Van Dam PJ, Griffin P, Reeves NS, Prior SJ, Paton B, Verma R, Giles A, Kirkwood L, Peterson GM.

Healthcare (Basel). 2019 Jul 9;7(3). pii: E90. doi: 10.3390/healthcare7030090.

5.

Bone metastases in the era of targeted treatments: insights from molecular biology.

Dewulf J, Vangestel C, Verhoeven Y, van Dam P, Elvas F, Van den Wyngaert T, Clézardin P.

Q J Nucl Med Mol Imaging. 2019 Jun;63(2):98-111. doi: 10.23736/S1824-4785.19.03203-5. Epub 2019 Jul 11.

PMID:
31298015
6.

PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

Tuyaerts S, Van Nuffel AMT, Naert E, Van Dam PA, Vuylsteke P, De Caluwé A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H.

BMC Cancer. 2019 May 28;19(1):506. doi: 10.1186/s12885-019-5676-3.

7.

RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.

van Dam PA, Verhoeven Y, Jacobs J, Wouters A, Tjalma W, Lardon F, Van den Wyngaert T, Dewulf J, Smits E, Colpaert C, Prenen H, Peeters M, Lammens M, Trinh XB.

Int J Mol Sci. 2019 May 2;20(9). pii: E2183. doi: 10.3390/ijms20092183. Review.

8.

Quality of Life and Pain Medication Use in Persons With Advanced Dementia Living in Long-Term Care Facilities.

van Dam PH, Caljouw MAA, Slettebø DD, Achterberg WP, Husebo BS.

J Am Med Dir Assoc. 2019 Apr 11. pii: S1525-8610(19)30245-2. doi: 10.1016/j.jamda.2019.02.019. [Epub ahead of print]

PMID:
30982716
9.

Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases.

Jansen YJL, Verset G, Schats K, Van Dam PJ, Seremet T, Kockx M, Van Laethem JB, Neyns B.

ESMO Open. 2019 Mar 5;4(2):e000464. doi: 10.1136/esmoopen-2018-000464. eCollection 2019.

10.

Genomic Characterization and Virulence Potential of Two Fusarium oxysporum Isolates Cultured from the International Space Station.

Urbaniak C, van Dam P, Zaborin A, Zaborina O, Gilbert JA, Torok T, Wang CCC, Venkateswaran K.

mSystems. 2019 Mar 19;4(2). pii: e00345-18. doi: 10.1128/mSystems.00345-18. eCollection 2019 Mar-Apr.

11.

ECG Adapted Fastest Route Algorithm to Localize the Ectopic Excitation Origin in CRT Patients.

Potyagaylo D, Chmelevsky M, van Dam P, Budanova M, Zubarev S, Treshkur T, Lebedev D.

Front Physiol. 2019 Mar 11;10:183. doi: 10.3389/fphys.2019.00183. eCollection 2019.

12.

The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).

Najim O, Huizing M, Papadimitriou K, Trinh XB, Pauwels P, Goethals S, Zwaenepoel K, Peterson K, Weyler J, Altintas S, van Dam P, Tjalma W.

Cancer Treat Res Commun. 2019;19:100123. doi: 10.1016/j.ctarc.2019.100123. Epub 2019 Feb 21.

PMID:
30826563
13.

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.

Van Berckelaer C, Rypens C, van Dam P, Pouillon L, Parizel M, Schats KA, Kockx M, Tjalma WAA, Vermeulen P, van Laere S, Bertucci F, Colpaert C, Dirix L.

Breast Cancer Res. 2019 Feb 18;21(1):28. doi: 10.1186/s13058-019-1108-1.

14.

A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).

Mayer IA, Prat A, Egle D, Blau S, Fidalgo JAP, Gnant M, Fasching PA, Colleoni M, Wolff AC, Winer EP, Singer CF, Hurvitz S, Estévez LG, van Dam PA, Kümmel S, Mundhenke C, Holmes F, Babbar N, Charbonnier L, Diaz-Padilla I, Vogl FD, Sellami D, Arteaga CL.

Clin Cancer Res. 2019 May 15;25(10):2975-2987. doi: 10.1158/1078-0432.CCR-18-3160. Epub 2019 Feb 5.

PMID:
30723140
15.

RANK/RANKL signaling inhibition may improve the effectiveness of checkpoint blockade in cancer treatment.

van Dam PA, Verhoeven Y, Trinh XB, Wouters A, Lardon F, Prenen H, Smits E, Baldewijns M, Lammens M.

Crit Rev Oncol Hematol. 2019 Jan;133:85-91. doi: 10.1016/j.critrevonc.2018.10.011. Epub 2018 Nov 3. Review.

16.

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, De Maeseneer D, Strijbos M, Bols A, Fransis K, Oeyen S, van Dam PJ, Van den Eynden G, Rutten A, Aly M, Nordström T, Van Laere S, Rantalainen M, Rajan P, Egevad L, Ullén A, Yachnin J, Dirix L, Grönberg H, Lindberg J.

Genome Med. 2018 Nov 21;10(1):85. doi: 10.1186/s13073-018-0595-5.

17.

Quality of life and paracetamol in advanced dementia (Q-PID): protocol of a randomised double-blind placebo-controlled crossover trial.

van Dam PH, Achterberg WP, Gussekloo J, Husebo BS, Caljouw MAA.

BMC Geriatr. 2018 Nov 14;18(1):279. doi: 10.1186/s12877-018-0974-1.

18.

Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing.

Leyva F, Zegard A, Taylor RJ, Foley PWX, Umar F, Patel K, Panting J, van Dam P, Prinzen FW, Marshall H, Qiu T.

J Am Heart Assoc. 2018 Aug 21;7(16):e008508. doi: 10.1161/JAHA.117.008508.

19.

A SIX1 homolog in Fusarium oxysporum f.sp. cubense tropical race 4 contributes to virulence towards Cavendish banana.

Widinugraheni S, Niño-Sánchez J, van der Does HC, van Dam P, García-Bastidas FA, Subandiyah S, Meijer HJG, Kistler HC, Kema GHJ, Rep M.

PLoS One. 2018 Oct 22;13(10):e0205896. doi: 10.1371/journal.pone.0205896. eCollection 2018.

20.

Quality indicators for the management of endometrial, cervical and ovarian cancer.

Bonte AS, Luyckx A, Wyckmans L, Trinh XB, van Dam PA.

Eur J Surg Oncol. 2019 Apr;45(4):528-537. doi: 10.1016/j.ejso.2018.10.051. Epub 2018 Oct 12.

PMID:
30337202
21.

Validation and Opportunities of Electrocardiographic Imaging: From Technical Achievements to Clinical Applications.

Cluitmans M, Brooks DH, MacLeod R, Dössel O, Guillem MS, van Dam PM, Svehlikova J, He B, Sapp J, Wang L, Bear L.

Front Physiol. 2018 Sep 20;9:1305. doi: 10.3389/fphys.2018.01305. eCollection 2018. Review.

22.

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Del Favero J, Rantalainen M, Rajan P, Sleijfer S, Ullén A, Yachnin J, Grönberg H, Van Laere SJ, Lindberg J, Dirix LY.

Clin Cancer Res. 2019 Mar 15;25(6):1766-1773. doi: 10.1158/1078-0432.CCR-18-1943. Epub 2018 Sep 12.

23.

Initial validation of a novel ECGI system for localization of premature ventricular contractions and ventricular tachycardia in structurally normal and abnormal hearts.

Misra S, van Dam P, Chrispin J, Assis F, Keramati A, Kolandaivelu A, Berger R, Tandri H.

J Electrocardiol. 2018 Sep - Oct;51(5):801-808. doi: 10.1016/j.jelectrocard.2018.05.018. Epub 2018 May 30.

PMID:
30177316
24.

Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer.

Rolfo C, Manca P, Salgado R, Van Dam P, Dendooven A, Machado Coelho A, Ferri Gandia J, Rutten A, Lybaert W, Vermeij J, Gevaert T, Weyn C, Lefebure A, Metsu S, Van Laere S, Peeters M, Pauwels P.

ESMO Open. 2018 Jul 23;3(5):e000398. doi: 10.1136/esmoopen-2018-000398. eCollection 2018.

25.

Potential new biomarkers for squamous carcinoma of the uterine cervix.

van Dam PA, Rolfo C, Ruiz R, Pauwels P, Van Berckelaer C, Trinh XB, Ferri Gandia J, Bogers JP, Van Laere S.

ESMO Open. 2018 Jun 28;3(4):e000352. doi: 10.1136/esmoopen-2018-000352. eCollection 2018.

26.

Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.

Barnhill R, Vermeulen P, Daelemans S, van Dam PJ, Roman-Roman S, Servois V, Hurbain I, Gardrat S, Raposa G, Nicolas A, Dendale R, Pierron G, Desjardins L, Cassoux N, Piperno-Neumann S, Mariani P, Lugassy C.

J Pathol Clin Res. 2018 Oct;4(4):227-240. doi: 10.1002/cjp2.105. Epub 2018 Aug 23.

27.

Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus.

Bruinstroop E, Meyer L, Brouwer CB, van Rooijen DE, van Dam PS.

Diabetes Ther. 2018 Jun;9(3):1369-1375. doi: 10.1007/s13300-018-0438-9. Epub 2018 May 19.

28.

Intentional overdose of dolutegravir/abacavir/lamivudine (Triumeq) in a 26-year-old man.

van Dam PM, van Geffen MW, Havenith TR, Posthouwer D.

Antivir Ther. 2018;23(6):549-552. doi: 10.3851/IMP3229.

PMID:
29533918
29.

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff I, van Dam V, Brouwer A, van Dam PJ, Van den Eynden G, Rutten A, Sleijfer S, Vandebroek J, Van Laere S, Dirix L.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.

PMID:
29431193
30.

Analysis of Metabolites from the Tricarboxylic Acid Cycle for Yeast and Bacteria Samples Using Gas Chromatography Mass Spectrometry.

Seifar RM, Ten Pierick A, van Dam PTN.

Methods Mol Biol. 2018;1730:277-282. doi: 10.1007/978-1-4939-7592-1_20.

PMID:
29363081
31.

Histopathological growth patterns as a candidate biomarker for immunomodulatory therapy.

van Dam PJ, Daelemans S, Ross E, Waumans Y, Van Laere S, Latacz E, Van Steen R, De Pooter C, Kockx M, Dirix L, Vermeulen PB.

Semin Cancer Biol. 2018 Oct;52(Pt 2):86-93. doi: 10.1016/j.semcancer.2018.01.009. Epub 2018 Jan 31. Review.

PMID:
29355613
32.

The role of Nuclear Factor-kappa B signaling in human cervical cancer.

Tilborghs S, Corthouts J, Verhoeven Y, Arias D, Rolfo C, Trinh XB, van Dam PA.

Crit Rev Oncol Hematol. 2017 Dec;120:141-150. doi: 10.1016/j.critrevonc.2017.11.001. Epub 2017 Nov 7. Review.

PMID:
29198328
33.

Torso geometry reconstruction and body surface electrode localization using three-dimensional photography.

Perez-Alday EA, Thomas JA, Kabir M, Sedaghat G, Rogovoy N, van Dam E, van Dam P, Woodward W, Fuss C, Ferencik M, Tereshchenko LG.

J Electrocardiol. 2018 Jan - Feb;51(1):60-67. doi: 10.1016/j.jelectrocard.2017.08.035. Epub 2017 Sep 1.

34.

Use of Comparative Genomics-Based Markers for Discrimination of Host Specificity in Fusarium oxysporum.

van Dam P, de Sain M, Ter Horst A, van der Gragt M, Rep M.

Appl Environ Microbiol. 2017 Dec 15;84(1). pii: e01868-17. doi: 10.1128/AEM.01868-17. Print 2018 Jan 1.

35.

Neoadjuvant trials can accelerate research on novel systemic treatment modalities in cancer of the uterine cervix.

van Dam PA, Rolfo C, Ruiz R.

Eur J Surg Oncol. 2017 Dec;43(12):2245-2247. doi: 10.1016/j.ejso.2017.09.018. Epub 2017 Sep 28. No abstract available.

PMID:
29029937
36.

Debatable issues in automated ECG reporting.

Macfarlane PW, Mason JW, Kligfield P, Sommargren CE, Drew B, van Dam P, Abächerli R, Albert DE, Hodges M.

J Electrocardiol. 2017 Nov - Dec;50(6):833-840. doi: 10.1016/j.jelectrocard.2017.08.027. Epub 2017 Sep 1.

PMID:
28985886
37.

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.

van Dam PJ, van der Stok EP, Teuwen LA, Van den Eynden GG, Illemann M, Frentzas S, Majeed AW, Eefsen RL, Coebergh van den Braak RRJ, Lazaris A, Fernandez MC, Galjart B, Laerum OD, Rayes R, Grünhagen DJ, Van de Paer M, Sucaet Y, Mudhar HS, Schvimer M, Nyström H, Kockx M, Bird NC, Vidal-Vanaclocha F, Metrakos P, Simoneau E, Verhoef C, Dirix LY, Van Laere S, Gao ZH, Brodt P, Reynolds AR, Vermeulen PB.

Br J Cancer. 2017 Nov 7;117(10):1427-1441. doi: 10.1038/bjc.2017.334. Epub 2017 Oct 5.

38.

What motivates their food choice? Children are key informants.

Waddingham S, Shaw K, Van Dam P, Bettiol S.

Appetite. 2018 Jan 1;120:514-522. doi: 10.1016/j.appet.2017.09.029. Epub 2017 Sep 30.

PMID:
28974432
39.

Mitochondrial genomes reveal recombination in the presumed asexual Fusarium oxysporum species complex.

Brankovics B, van Dam P, Rep M, de Hoog GS, J van der Lee TA, Waalwijk C, van Diepeningen AD.

BMC Genomics. 2017 Sep 18;18(1):735. doi: 10.1186/s12864-017-4116-5.

40.

A new anatomical view on the vector cardiogram: The mean temporal-spatial isochrones.

van Dam PM.

J Electrocardiol. 2017 Nov - Dec;50(6):732-738. doi: 10.1016/j.jelectrocard.2017.08.010. Epub 2017 Aug 12.

PMID:
28916173
41.

Time trends (2006-2015) of quality indicators in EUSOMA-certified breast centres.

van Dam PA, Tomatis M, Marotti L, Heil J, Mansel RE, Rosselli Del Turco M, van Dam PJ, Casella D, Bassani LG, Danei M, Denk A, Egle D, Emons G, Friedrichs K, Harbeck N, Kiechle M, Kimmig R, Koehler U, Kuemmel S, Maass N, Mayr C, Prové A, Rageth C, Regolo L, Lorenz-Salehi F, Sarlos D, Singer C, Sohn C, Staelens G, Tinterri C, Audisio R, Ponti A; eusomaDB Working Group.

Eur J Cancer. 2017 Nov;85:15-22. doi: 10.1016/j.ejca.2017.07.040. Epub 2017 Sep 4.

PMID:
28881247
42.

A mobile pathogenicity chromosome in Fusarium oxysporum for infection of multiple cucurbit species.

van Dam P, Fokkens L, Ayukawa Y, van der Gragt M, Ter Horst A, Brankovics B, Houterman PM, Arie T, Rep M.

Sci Rep. 2017 Aug 22;7(1):9042. doi: 10.1038/s41598-017-07995-y.

43.

The Distribution of Miniature Impala Elements and SIX Genes in the Fusarium Genus is Suggestive of Horizontal Gene Transfer.

van Dam P, Rep M.

J Mol Evol. 2017 Aug;85(1-2):14-25. doi: 10.1007/s00239-017-9801-0. Epub 2017 Jul 25.

44.

Microscale Quantitative Analysis of Polyhydroxybutyrate in Prokaryotes Using IDMS.

Velasco Alvarez MI, Ten Pierick A, van Dam PTN, Maleki Seifar R, van Loosdrecht MCM, Wahl SA.

Metabolites. 2017 May 17;7(2). pii: E19. doi: 10.3390/metabo7020019.

45.

The Consortium for Electrocardiographic Imaging.

Coll-Font J, Dhamala J, Potyagaylo D, Schulze WH, Tate JD, Guillem MS, van Dam P, Dossel O, Brooks DH, Macleod RS.

Comput Cardiol (2010). 2016 Sep;43:325-328. Epub 2017 Mar 2.

46.

FGFR a promising druggable target in cancer: Molecular biology and new drugs.

Porta R, Borea R, Coelho A, Khan S, Araújo A, Reclusa P, Franchina T, Van Der Steen N, Van Dam P, Ferri J, Sirera R, Naing A, Hong D, Rolfo C.

Crit Rev Oncol Hematol. 2017 May;113:256-267. doi: 10.1016/j.critrevonc.2017.02.018. Epub 2017 Mar 23. Review.

PMID:
28427515
47.

Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.

De Laere B, van Dam PJ, Whitington T, Mayrhofer M, Diaz EH, Van den Eynden G, Vandebroek J, Del-Favero J, Van Laere S, Dirix L, Grönberg H, Lindberg J.

Eur Urol. 2017 Aug;72(2):192-200. doi: 10.1016/j.eururo.2017.01.011. Epub 2017 Jan 16.

PMID:
28104311
48.
49.

Non-canonical Helitrons in Fusarium oxysporum.

Chellapan BV, van Dam P, Rep M, Cornelissen BJ, Fokkens L.

Mob DNA. 2016 Dec 9;7:27. eCollection 2016.

50.

Care-Related Quality of Life of Informal Caregivers After Geriatric Rehabilitation.

van Dam PH, Achterberg WP, Caljouw MA.

J Am Med Dir Assoc. 2017 Mar 1;18(3):259-264. doi: 10.1016/j.jamda.2016.09.020. Epub 2016 Nov 9.

PMID:
27838337

Supplemental Content

Loading ...
Support Center